Written answers
Tuesday, 5 November 2024
Department of Health
Medicinal Products
Seán Crowe (Dublin South West, Sinn Fein)
Link to this: Individually | In context | Oireachtas source
998. To ask the Minister for Health further to Parliamentary Question No. 707 of 11 June 2024, if the HSE pricing and reimbursement application process with regard to the drugs payment scheme has been completed; if melatonin will now be covered under the scheme and the justification if not; and if he will make a statement on the matter. [43931/24]
Stephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.
Róisín Shortall (Dublin North West, Social Democrats)
Link to this: Individually | In context | Oireachtas source
999. To ask the Minister for Health if the HSE intends to no longer prescribe a treatment for Covid-19 in high-risk patients (details supplied); the basis for this decision; the engagements he has had with patient representative groups; and if he will make a statement on the matter. [43935/24]
Stephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
As the Deputy's question refers to an operational matter which is the responsibility of the HSE, I have asked the HSE to respond to the Deputy directly.
No comments